NL157501B - PHARMACEUTICAL TABLET CONTAINING A COMBINATION OF A 2,4-DIAMINO-5-BENZYLPYRIMIDINE DERIVATIVE WITH A SULPHONAMIDE, BOTH WITH A PARTICLE SIZE OF LESS THAN 40 UM, A FITTING AGENT AND A GRANULATING AGENT OF THE PREPARANT, AND THE SAME PRODUCT. - Google Patents

PHARMACEUTICAL TABLET CONTAINING A COMBINATION OF A 2,4-DIAMINO-5-BENZYLPYRIMIDINE DERIVATIVE WITH A SULPHONAMIDE, BOTH WITH A PARTICLE SIZE OF LESS THAN 40 UM, A FITTING AGENT AND A GRANULATING AGENT OF THE PREPARANT, AND THE SAME PRODUCT.

Info

Publication number
NL157501B
NL157501B NL7501680.A NL7501680A NL157501B NL 157501 B NL157501 B NL 157501B NL 7501680 A NL7501680 A NL 7501680A NL 157501 B NL157501 B NL 157501B
Authority
NL
Netherlands
Prior art keywords
agent
preparant
sulphonamide
diamino
particle size
Prior art date
Application number
NL7501680.A
Other languages
Dutch (nl)
Other versions
NL7501680A (en
NL157501C (en
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9820242&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL157501(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of NL7501680A publication Critical patent/NL7501680A/en
Publication of NL157501B publication Critical patent/NL157501B/en
Application granted granted Critical
Publication of NL157501C publication Critical patent/NL157501C/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NL7501680.A 1974-02-14 1975-02-13 PHARMACEUTICAL TABLET CONTAINING A COMBINATION OF A 2,4-DIAMINO-5-BENZYL-PYRIMIDINE DERIVATIVE WITH A SULFONAMIDE, BOTH MICRONIZED, IN ADDITION TO AT LEAST A SPLIT AND A GRANULATOR, AT THE SAME TIME, AT THE SAME TIME. NL157501C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB6758/74A GB1499672A (en) 1974-02-14 1974-02-14 Tablet formulation

Publications (3)

Publication Number Publication Date
NL7501680A NL7501680A (en) 1975-08-18
NL157501B true NL157501B (en) 1978-08-15
NL157501C NL157501C (en) 1981-07-16

Family

ID=9820242

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7501680.A NL157501C (en) 1974-02-14 1975-02-13 PHARMACEUTICAL TABLET CONTAINING A COMBINATION OF A 2,4-DIAMINO-5-BENZYL-PYRIMIDINE DERIVATIVE WITH A SULFONAMIDE, BOTH MICRONIZED, IN ADDITION TO AT LEAST A SPLIT AND A GRANULATOR, AT THE SAME TIME, AT THE SAME TIME.

Country Status (32)

Country Link
JP (1) JPS5545043B2 (en)
AT (1) AT344915B (en)
AU (1) AU468465B2 (en)
BE (1) BE825496A (en)
CA (1) CA980688A (en)
CH (1) CH618432A5 (en)
CS (1) CS220306B2 (en)
CY (1) CY1052A (en)
DD (1) DD118228A5 (en)
DE (1) DE2506099C2 (en)
DK (1) DK143247C (en)
DO (1) DOP1979002763A (en)
ES (1) ES434688A1 (en)
FI (1) FI62219C (en)
FR (1) FR2260993B1 (en)
GB (1) GB1499672A (en)
GT (1) GT197960431A (en)
HK (1) HK23980A (en)
HU (1) HU171536B (en)
IE (1) IE40599B1 (en)
IL (1) IL46629A (en)
IN (1) IN141019B (en)
KE (1) KE3038A (en)
LU (1) LU71835A1 (en)
MC (1) MC1053A1 (en)
MY (1) MY8100054A (en)
NL (1) NL157501C (en)
NO (1) NO146043C (en)
PH (1) PH14575A (en)
SE (1) SE427898B (en)
ZA (1) ZA75930B (en)
ZM (1) ZM1875A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1533243A (en) * 1975-02-13 1978-11-22 Wellcome Found Tablet formulation
US4115563A (en) * 1977-03-14 1978-09-19 Sterling Drug Inc. Pharmaceutical steroid formulation
GB1601833A (en) * 1978-02-06 1981-11-04 Wellcome Found Antacid formulation
HU183408B (en) 1981-04-28 1984-05-28 Chinoin Gyogyszer Es Vegyeszet Process for producing oral ratard pharmaceutical compositions
GB8603964D0 (en) * 1986-02-18 1986-03-26 Cooper Animal Health Ltd Compositions
US5190760A (en) * 1989-07-08 1993-03-02 Coopers Animal Health Limited Solid pharmaceutical composition
GB8915716D0 (en) * 1989-07-08 1989-08-31 Coopers Animal Health Pharmaceutical compositions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1445983A (en) * 1972-11-06 1976-08-11 Wellcome Found Pharmaceutical formulations

Also Published As

Publication number Publication date
NO146043B (en) 1982-04-13
JPS5545043B2 (en) 1980-11-15
CS220306B2 (en) 1983-03-25
FR2260993A1 (en) 1975-09-12
GB1499672A (en) 1978-02-01
GT197960431A (en) 1981-05-05
HK23980A (en) 1980-05-09
ES434688A1 (en) 1977-04-01
HU171536B (en) 1978-01-28
DK143247B (en) 1981-08-03
DE2506099C2 (en) 1983-11-03
NL7501680A (en) 1975-08-18
PH14575A (en) 1981-09-24
CY1052A (en) 1980-08-01
IL46629A0 (en) 1975-05-22
DK52875A (en) 1975-10-06
CA980688A (en) 1975-12-30
IE40599B1 (en) 1979-07-04
JPS50116627A (en) 1975-09-12
DOP1979002763A (en) 1987-06-18
KE3038A (en) 1980-04-25
DE2506099A1 (en) 1975-08-21
IN141019B (en) 1977-01-08
AU7817075A (en) 1976-01-15
ZA75930B (en) 1976-01-28
MY8100054A (en) 1981-12-31
FI62219C (en) 1982-12-10
DD118228A5 (en) 1976-02-20
IE40599L (en) 1975-08-14
AU468465B2 (en) 1976-01-15
CH618432A5 (en) 1980-07-31
ATA108475A (en) 1977-12-15
ZM1875A1 (en) 1975-12-22
BE825496A (en) 1975-05-29
DK143247C (en) 1981-11-30
NL157501C (en) 1981-07-16
NO146043C (en) 1982-08-04
MC1053A1 (en) 1976-02-20
SE427898B (en) 1983-05-24
FR2260993B1 (en) 1978-06-30
LU71835A1 (en) 1975-06-24
IL46629A (en) 1977-07-31
FI62219B (en) 1982-08-31
SE7501595L (en) 1975-08-15
NO750467L (en) 1975-08-15
FI750398A (en) 1975-08-15
AT344915B (en) 1978-08-25

Similar Documents

Publication Publication Date Title
NL186633C (en) PROCESS FOR THE PREPARATION OF A MEDICINAL PRODUCT WITH ANTI-ARRHYTHIC EFFECT AND PROCESS FOR THE PREPARATION OF BENZAMIDE DERIVATIVES USED THEREIN
NL7506757A (en) AGENT FOR INTRAVASCULAR ADMINISTRATION.
NL177980C (en) METHOD FOR MANUFACTURING A FIXED, INTAKABLE MEDICINE PREPARATION AND CONTAINER CONTAINING SUCH A PREPARATION
NL7501365A (en) METHOD OF CONTROLLING THE DELAYED TIME OF A MEDICINAL PRODUCT.
NL7703752A (en) METHOD OF PREPARING A MEDICINAL PRODUCT AGAINST CANCER AND METHOD OF PREPARING AN ACTIVE COMPONENT AS WELL AS THE PREPARED MEDICINAL PRODUCT.
NL7710380A (en) PROCESS FOR PREPARING A MEDICINAL PRODUCT, SUCH MEDICINAL PRODUCT AND PROCEDURE FOR PREPARING SUITABLE ACTIVE COMPOUNDS.
NL167436C (en) PROCESS FOR THE PREPARATION OF 7-BETA-ACYLAMINO-7 ALFA-ALKOXYCEPHALOSPORINES AND 6-BETA-ACYLAMINO-6 ALFA-ALKOXYPENICILLIN, AND FORMED MEDICINAL PRODUCT.
NL162652C (en) PROCESS FOR PREPARING A MEDICINAL PRODUCT AGAINST THE ANTIGEN-ANTIBODY REACTION CONTAINING A CHROMON-2-CARBONIC ACID DERIVATIVE AND THE MEDICINAL PRODUCTS USED AT THE USE OF THIS PROCESS, AND FOR IT PROPERTIED AT THE SAME PROPERTIES, AT THE SAME TIME.
NL157501B (en) PHARMACEUTICAL TABLET CONTAINING A COMBINATION OF A 2,4-DIAMINO-5-BENZYLPYRIMIDINE DERIVATIVE WITH A SULPHONAMIDE, BOTH WITH A PARTICLE SIZE OF LESS THAN 40 UM, A FITTING AGENT AND A GRANULATING AGENT OF THE PREPARANT, AND THE SAME PRODUCT.
NL7709508A (en) METHODS FOR THE PREPARATION OF AMINO ALKYLIDES-AMINO-1,4-DIHYDROPYRIDINS, AND THE USE OF THESE COMPOUNDS AS A MEDICINAL PRODUCT.
NL7603043A (en) PROCEDURE FOR PREPARING PROSTAGLANDIN CONTAINING FREEZED POWDER AND PROCEDURE FOR PREPARING A MEDICINAL PRODUCT WITH PROSTAGLANDIN ACTION.
NL7604442A (en) STORAGE AND DISPENSING SYSTEM FOR THE MANUFACTURE OF COLORS.
NL160726C (en) DEVICE FOR DELIVERING AN ACTIVE AGENT, SUCH AS A MEDICINAL PRODUCT.
NL7514970A (en) PROCEDURE FOR PREPARING A MEDICINAL PRODUCT, SUCH MEDICINAL PRODUCT AND PROCEDURE FOR PREPARING SUITABLE ACTIVE COMPONENTS.
NL162839C (en) Apparatus for the delivery of a medicament in finely divided powder form.
NL169470C (en) PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION AND PROCESS FOR PREPARING A 2- (2-CHLOROPHENYLAMINO) -IMIDAZOLINE- (2) DERIVATIVE.
NL153171B (en) PROCESS FOR THE PREPARATION OF INDAN DERIVATIVES AND PROCESS FOR THE PREPARATION OF A PREPARATION.
NL7512637A (en) PROCESS FOR THE PREPARATION OF A MEDICINAL PRODUCT, THE MEDICINAL PRODUCT CONTAINED THEREFORE AND PROCESS FOR THE PREPARATION OF THE ACTIVE COMPONENT.
NL7505521A (en) PROCESS FOR THE PREPARATION OF ANTI-ARTERIOSCLEROTIC ACTIVE SUBSTANCES, PROCESS FOR THE PREPARATION OF A MEDICINAL PRODUCT WITH SUCH ACTION AND A MEDICINAL PRODUCT.
NL7512896A (en) PROCEDURE FOR THE PREPARATION OF NAPHTHALENE DERIVATIVES AND PROCEDURE FOR THE PREPARATION OF A MEDICINAL PRODUCT ON THE BASIS.
NL7411286A (en) PROCESS FOR REDUCING THE PARTICLE SIZE OF AN AGGLOMERATED AND / OR AGGREATED SOLID MATERIAL WITH A PARTICLE SIZE OF LESS THAN 0.1 MM.
NL172446C (en) PROCESS FOR THE PREPARATION OF 4-ARYL-1- (4,4-DIARYLBUTYL) 4-HYDROXYPIPERIDINES AND PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS.
NL7501317A (en) POLYMERIZABLE SULPHONAMIDE AND POLYMER IN THIS METHOD FOR THE PREPARATION OF THE MDE PRODUCTS.
NL167643C (en) METHOD FOR PACKING A PRODUCT IN A PLEXIBLE HOLDER OR BAG FREE OF AIR
NL7500868A (en) PROCEDURE FOR PREPARING MEDICINAL PRODUCTS AND NEW CYCLOPENT DERIVATIVES.

Legal Events

Date Code Title Description
P2G Not automatically granted patents, but text of patent specification is modified with respect to the text of examined patent ap
V4 Discontinued because of reaching the maximum lifetime of a patent